欧美日韩精品无码专区,成年无码av片,成品漫画免登录去广告版,亚洲精品一区国产

美國LipoScience
LipoScience是領(lǐng)先的生物分析診斷公司，主要使用核磁共振方法（NMR）通過分析血液中脂蛋白的成分進行心血管疾病的分級。這項技術(shù)由于北卡州立大學(xué)生物化學(xué)專家James Otvos提出，他目前是該公司的首席科學(xué)顧問。測試結(jié)果目前已廣泛得到Mdeicare，TRICARE，WellPoint，United HealthCare 等醫(yī)療保險公司認(rèn)可。
LipoScience 開創(chuàng)了一個基于 NMR 技術(shù)進行個性化診斷的新領(lǐng)域。加強并拓寬我們的專有診斷測試能力

LipoScience is a highly innovative, diagnostic company focused on changing the way heart disease, diabetes* and other metabolic diseases are assessed and managed.

We develop proprietary tests based on Nuclear Magnetic Resonance (NMR), an information-rich technology that produces a digital representation of the molecules present in a simple blood sample.

Over 8 million tests performed since 1999 to benefit physicians and their patients. This test directly measures lipoprotein particles and provides physicians and their patients more information to manage their risk for heart disease and diabetes.

The company is preparing to decentralize its proprietary platform with a broad array of high value NMR based assays, in support of driving toward new clinical standards of care.

We have broad opportunities for growth in our diagnostic, research, and laboratory businesses. We are actively pursuing these opportunities with the support of our employees, our customers, and our industry partners.

* The LP-IR test is only available through the LipoScience laboratory.